Jincheng Bio-Pharmaceutical
Jincheng Bio-Pharmaceutical, a leading player in the biopharmaceutical industry, is headquartered in China (CN) and operates extensively across various regions. Founded in the early 2000s, the company has achieved significant milestones, establishing itself as a key innovator in the development of therapeutic solutions. Specialising in the research, development, and manufacturing of biologics and pharmaceuticals, Jincheng Bio-Pharmaceutical is renowned for its unique product offerings, which include monoclonal antibodies and recombinant proteins. These products are distinguished by their high efficacy and safety profiles, catering to a diverse range of medical needs. With a strong market position, Jincheng Bio-Pharmaceutical has garnered recognition for its commitment to quality and innovation, contributing to advancements in healthcare and improving patient outcomes globally.
DitchCarbon Score
How does Jincheng Bio-Pharmaceutical's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Jincheng Bio-Pharmaceutical's score of 0 is lower than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Jincheng Bio-Pharmaceutical's reported carbon emissions
Jincheng Bio-Pharmaceutical, headquartered in CN, currently does not provide specific carbon emissions data for recent years, as no emissions figures are available. Additionally, there are no documented reduction targets or climate pledges outlined in their initiatives. This lack of publicly available information on emissions and commitments suggests that Jincheng Bio-Pharmaceutical may still be in the early stages of developing a comprehensive climate strategy. As the biopharmaceutical industry increasingly focuses on sustainability, it is essential for companies like Jincheng to establish clear targets and transparent reporting to align with global climate goals.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Jincheng Bio-Pharmaceutical is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
